AbbVie is a popular stock with dividend investors for its high starting yield and continuous dividend increases. AbbVie is a ...

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday it has obtained an interchangeability approval for ...

The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic ...

Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

Celltrion, Inc. announced that the U.S. Food and Drug Administration granted an interchangeable designation to ...

Humira (adalimumab) is a prescription drug that’s used to treat certain conditions, such as rheumatoid arthritis. Humira can cause side effects that range from mild to serious. Examples include ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

Dosage for Humira (adalimumab) may vary based on the condition it’s being used to treat. Also, your doctor may adjust your dosage over the course of your treatment. Be sure to take the Humira ...

The prescribed dosage for Humira (adalimumab) may vary depending on a person’s individual treatment plan. Other factors, including specific diagnosis, body weight, and medical history ...

Humira has possible interactions with alcohol, some other drugs, and certain supplements. Examples include TNF blockers, other biologics, and corticosteroids. Humira also interacts with vaccines.

Yuflyma is a high-concentration and citrate-free formulation of Humira biosimilar, approved for multiple inflammatory ...